Compare Pfizer Inc (PFE) vs Vanguard High Dividend Yield ETF (VYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Vanguard High Dividend Yield ETF — how do they compare? Pfizer Inc trades at $28.28 (market cap $158.56B), while Vanguard High Dividend Yield ETF trades at $158.75 (market cap $100.80B). The key difference: Pfizer Inc is the larger of the two by market cap, and Pfizer Inc pays a 6.18% dividend while Vanguard High Dividend Yield ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Vanguard High Dividend Yield ETF for 139 Days on average.
| PFE | VYM | |
|---|---|---|
Market Cap | $158.56B | $100.80B |
Volume | 44,138,282 | 908,176 |
Sector | Health | — |
52-Week High | $29.02 | $167.03 |
52-Week Low | $23.67 | $137.47 |
Typical Hold Time | 158 Days | 139 Days |
Enterprise Value | $210.06B | — |
Dividend Yield | 6.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.82, down 0.64% on the day, with a bullish technical signal from moving averages and oversold RSI levels. The company reported revenue of $62.58B in 2025 with a net income margin of 6.8%, and has beaten earnings estimates for three consecutive quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline, positioning for a catalyst-rich 2026.
The stock presents a value opportunity with a forward P/E of 36.61 and consensus price target of $29.17, but faces risks from patent cliffs and volatile cash flows. Analyst sentiment is mixed with 40% buy ratings, while institutional outlook remains cautious amid earnings pressure and competitive threats in the pharma sector.
VYM trades at $158.25, up 0.51% today, with a bearish technical signal from moving averages. The ETF maintains consistent dividend distributions, with the next payment scheduled for September 2026. Recent news highlights VYM's position as a reliable dividend ETF, though some analysts suggest alternative portfolios may offer superior returns. The fund's broad diversification across nearly 600 holdings provides stability but faces criticism for including companies with recent dividend cuts.
VYM offers steady income with moderate yield but faces competition from higher-performing dividend ETFs. Key risks include exposure to companies with potential dividend reductions and underperformance relative to peer strategies. The fund's low expense ratio and diversification remain attractive for conservative income investors seeking reliable quarterly payments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Vanguard High Dividend Yield ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →
